Diagnosis And Treatment Of Follicular Lymphoma An Update

Diagnosis And Treatment Of Follicular Lymphoma An Update Abstract. over the last few years, there have been many changes in the management of patients with follicular lymphoma, resulting in improvements in progression free survival and quality of life. in addition to established regimens such as radiotherapy and immunochemotherapy, new treatment options are on the horizon. Disease overview: follicular lymphoma (fl) is generally an indolent b cell lymphoproliferative disorder of transformed follicular center b cells. fl is characterized by diffuse lymphadenopathy, bone marrow involvement, and splenomegaly. extranodal involvement is less common. cytopenias are relatively common but constitutional symptoms of fever.

Pdf Diagnosis And Treatment Of Follicular Lymphoma An Update Fl is the second most common lymphoma diagnosed in the united states and western europe, 1 accounting for approximately 35% of all non hodgkin lymphomas (nhls), and 70% of indolent lymphomas. 2 the median age at diagnosis of 65 years. 3 the incidence is slightly increased among relatives of persons with fl. 4, 5. Follicular lymphoma is the second most common lymphoma diagnosed in the united states and western europe, 1 accounting for approximately 35% of all non hodgkin lymphomas (nhls), and 70% of indolent lymphomas. 2 the median age at diagnosis is 65 years. 3 the incidence is slightly increased among relatives of persons with fl. 4, 5. Conclusion. given the good long term prognosis of fl, the treatment must be chosen with care and thorough follow up is necessary to ensure detection of late sequelae such as second malignancies or organ damage. follicular lymphoma (fl) is a malignancy that develops from the b cell lineage in the lymphatic system. In this article, we will discuss the diagnosis, prognostication, and management of follicular lymphoma in treatment naïve and relapsed patients. epidemiology the incidence of fl is highest in the western population with 3.18 cases per 100,000 people annually in the united states and it constitutes about 20 25% of all nhls [ 1 3 ].

Pdf Diagnosis And Treatment Of Follicular Lymphoma An Update Conclusion. given the good long term prognosis of fl, the treatment must be chosen with care and thorough follow up is necessary to ensure detection of late sequelae such as second malignancies or organ damage. follicular lymphoma (fl) is a malignancy that develops from the b cell lineage in the lymphatic system. In this article, we will discuss the diagnosis, prognostication, and management of follicular lymphoma in treatment naïve and relapsed patients. epidemiology the incidence of fl is highest in the western population with 3.18 cases per 100,000 people annually in the united states and it constitutes about 20 25% of all nhls [ 1 3 ]. Epidemiology. follicular lymphoma (fl) is the most common non hodgkin indolent lymphoma, accounting for around 15% of all cases of lymphoid malignancies in our setting. 1 its incidence is about 5 cases per 100,000 people per year, 2 and it is slightly higher in men than in women. the median age at diagnosis is around 60 years. When symptoms do develop, the standard treatment has been to combine chemotherapy with an antibody drug that targets the cd20 protein on follicular lymphoma cells. that approach usually succeeds at putting the disease in remission, but the chemotherapy can trigger a range of adverse side effects, particularly among older patients, who.

Diagnosis And Treatment Of Follicular Lymphoma An Update Epidemiology. follicular lymphoma (fl) is the most common non hodgkin indolent lymphoma, accounting for around 15% of all cases of lymphoid malignancies in our setting. 1 its incidence is about 5 cases per 100,000 people per year, 2 and it is slightly higher in men than in women. the median age at diagnosis is around 60 years. When symptoms do develop, the standard treatment has been to combine chemotherapy with an antibody drug that targets the cd20 protein on follicular lymphoma cells. that approach usually succeeds at putting the disease in remission, but the chemotherapy can trigger a range of adverse side effects, particularly among older patients, who.